Company
Headquarters: London, United Kingdom
Employees: 18
CEO: Dr. Thomas James Oakley B.Sc.
£6.4 Million
GBP as of July 1, 2025
US$8.7 Million
Company | Market Cap (USD) |
---|---|
Veeva Systems Inc. | $46.46 B |
GE HealthCare | $34.85 B |
Change Healthcare Inc. | $9.03 B |
M3, Inc. | $8.98 B |
Pro Medicus Limited | $8.96 B |
Company | Market Cap (USD) |
---|---|
Lilly | $699.59 B |
Johnson & Johnson | $374.29 B |
AbbVie | $336.94 B |
Novo Nordisk | $309.91 B |
UnitedHealth Group | $279.90 B |
Feedback plc, a medical imaging technology company, provides software and systems to those working in the field of medical imaging. Its products include TexRAD, a patent-protected software tool, which extracts and quantifies texture features in radiological images, assists research into all tumour types, and uncovers biomarkers in medical images; and TexRAD Lung, a software tool for the analysis of lung cancer for clinical use in the European Union. The company also offers Cadran image platform that provides hospitals and research institutes with a comprehensive picture archiving communication system for medical images, as well as equips users with a platform for image handling from all imaging modalities, such as CT and PET scanners; and Bleepa, a secure clinical communications platform that facilitates the sharing of clinical-grade medical images. Feedback plc was incorporated in 1958 and is headquartered in London, the United Kingdom.
Last Financial Reports Date | Nov. 30, 2023 |
Revenue TTM | £885,997 |
EBITDA | £-3,910,015 |
Gross Profit TTM | £940,721 |
Profit Margin | 91.78% |
Operating Margin | -488.56% |
Quarterly Revenue Growth | -24.10% |
Feedback plc has the following listings and related stock indices.
Stock: LSE: FDBK wb_incandescent